Literature DB >> 9261964

Analysis of ovine IL-1 beta production in vivo and in vitro by enzyme immunoassay and immunohistochemistry.

J S Rothel1, L Hurst, H F Seow, M Pépin, P Berthon, L A Corner, P R Wood.   

Abstract

A monoclonal antibody (mAb) specific for ovine IL-1 beta was produced and, in conjunction with a polyclonal rabbit antiserum, used to develop a sensitive enzyme immunoassay (EIA) for ovine interleukin 1 beta (IL-1 beta). The mAb neutralised the activity of recombinant ovine IL-1 beta (rOvIL-1 beta) and native OvIL-1 in an ovine thymocyte proliferation assay. However, it did not neutralise the biological activity of rOvIL-1 beta in the murine NOB1/CTLL assay. The mAb did not react with rOvIL-1 alpha, IL-2, IL-4, IL-8, tumor necrosis factor-alpha, gamma-interferon or recombinant human IL-1 beta in indirect EIA. Immunohistological staining of activated alveolar macrophages and frozen lymph node sections sections demonstrated that the mAb detected IL-1 beta secreted by ovine macrophages (CD11c-positive). The EIA was highly sensitive, detecting less than 50 pg ml-1 of rOvIL-1 beta and low levels of native IL-1 beta in supernatants from lipopolysaccharide-stimulated macrophages. The EIA did not detect heat-inactivated IL-1 beta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261964     DOI: 10.1016/s0165-2427(96)05754-6

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus.

Authors:  Xiaodi Chen; Virginia Hovanesian; Syed Naqvi; Yow-Pin Lim; Richard Tucker; John E Donahue; Edward G Stopa; Barbara S Stonestreet
Journal:  Brain Behav Immun       Date:  2017-08-02       Impact factor: 7.217

2.  Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.

Authors:  Aparna Patra; Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Yow-Pin Lim; James F Padbury; William A Banks; Barbara S Stonestreet
Journal:  Neuroscience       Date:  2017-01-09       Impact factor: 3.590

3.  In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.

Authors:  X Chen; S W Threlkeld; E E Cummings; G B Sadowska; Y-P Lim; J F Padbury; S Sharma; B S Stonestreet
Journal:  J Comp Pathol       Date:  2012-07-20       Impact factor: 1.311

4.  Neutralizing anti-interleukin-1β antibodies modulate fetal blood-brain barrier function after ischemia.

Authors:  Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Jeong-Eun Kim; Erin E Cummings; Courtney A Bodge; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; Steven W Threlkeld; William A Banks; Barbara S Stonestreet
Journal:  Neurobiol Dis       Date:  2014-09-26       Impact factor: 5.996

5.  Cytokine release by ovine macrophages following infection with Chlamydia psittaci.

Authors:  G Entrican; R Wilkie; P McWaters; J Scheerlinck; P R Wood; J Brown
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Ovine proinflammatory cytokines cross the murine blood-brain barrier by a common saturable transport mechanism.

Authors:  Steven W Threlkeld; Jessica L Lynch; Kristin M Lynch; Grazyna B Sadowska; William A Banks; Barbara S Stonestreet
Journal:  Neuroimmunomodulation       Date:  2010-05-28       Impact factor: 2.492

Review 7.  Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period.

Authors:  Clémence Disdier; Xiaodi Chen; Jeong-Eun Kim; Steven W Threlkeld; Barbara S Stonestreet
Journal:  Brain Sci       Date:  2018-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.